The Food and Drug Administration (FDA) has ordered the recall of Lay's potato chips in Oregon and Washington due to the ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
An injectable blood pressure drug has been recalled after the FDA has warned it could cause side effects, such as stroke or death.
Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...
Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...
The FDA issued a warning letter to ProRx, a compounding facility in Exton, Penn., after an inspection raised serious concerns regarding the safety and compliance of its drug products. The facility, ...
After the Red No. 3 ban, there are now eight color additives approved by the FDA. They are FD&C Blue No. 1, FD&C Blue No. 2, ...
The Lay’s potato chips recall for undeclared milk was upgraded to the FDA’s highest risk level. Find out what this means for ...
The FDA just set the highest risk level—class 1—for the recall of Lay's Classic Potato Chips amid concern that they contain ...
The FDA has raised the risk level on a recall of Lay’s potato chips to the highest level, warning the recalled product could ...
In an advisory issued Friday, Surgeon General Vivek Murthy recommended that labels on alcoholic beverages be updated to include a warning about the risk of cancer associated with alcohol ...
Hologic received a warning letter in December from the Food and Drug Administration related to safety concerns with the company’s Biozorb implantable radiographic markers. The FDA found that ...